Johnson and Johnson India unveils enhanced paternity leave Ruby Khatun Khatun10 Sept 2017 9:34 AM ISTNew Delhi: Johnson and Johnson India on Wednesday announced an enhanced paternity leave policy under which new and adoptive fathers will be entitled...
CCI to study unfair practices in Indian pharma, healthcare, releases RFP Ruby Khatun Khatun9 Sept 2017 1:01 PM ISTNEW DELHI: The Competition Commission of India (CCI) has released a request for proposals (RFP) from agencies to conduct a study on anti-competitive...
OrbiMed lines up 551 million dollar healthcare PE fund for China, India Ruby Khatun Khatun9 Sept 2017 10:17 AM ISTNEW YORK: OrbiMed, a leading investment firm focused on the healthcare sector, announced the closing of its third Asia-focused private equity fund,...
NBCC bags Rs 464 crore contract from health ministry Ruby Khatun Khatun9 Sept 2017 10:01 AM ISTNew Delhi: State-owned construction firm NBCC has bagged a Rs 464 crore contract from the health ministry for expansion of a sports injury centre in...
Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in Immuno-Oncology Ruby Khatun Khatun9 Sept 2017 9:57 AM ISTKENILWORTH, N.J. & MUNICH: Merck, known as MSD outside the United States and Canada, and Rigontec announced that Merck will acquire...
Co-Diagnostics to sign purchase agreement with MEDCIS Pathlabs Ruby Khatun Khatun9 Sept 2017 9:34 AM ISTSANDY, Utah: Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company"), a molecular diagnostics company with a unique, proprietary platform for the...
Dr Reddys Vizag unit gets 6 observations by German regulator Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTNew Delhi: Dr Reddy's Laboratories (DRL) said the German drug regulator has concluded the audit of its Visakhapatnam formulations facility with six...
GSK bets on pioneering cancer therapy with Adaptimmune deal Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTLONDON: GlaxoSmithKline (GSK) said it has licensed the rights to Adaptimmune's pioneering T-cell therapy program to boost its pipeline in oncology,...
Eisai signs agreement with Merck to expand enrollment of combination study for Lenvima and Pembrolizumab Ruby Khatun Khatun8 Sept 2017 1:28 PM ISTTOKYO: Eisai Co., Ltd. has announced that it has signed an agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside of the...
Indias loss is over Rs 60 lakh crore each year due to poor healthcare: Vazirani Ruby Khatun Khatun8 Sept 2017 1:28 PM ISTMumbai: The 10th Medtech Conference of Confederation of Indian Industries (CII) witnessed the coming together of officials from the Central and State...
Technology can help reduce healthcare costs: Health Minister Ruby Khatun Khatun8 Sept 2017 1:24 PM ISTNew Delhi: The government is committed to technology integration in the health sector, Minister of State for Health Anupriya Patel said on Thursday,...
Patanjali Versus Dabur: HC restrains Patanjali from airing ads to promote Chyawanprash Ruby Khatun Khatun8 Sept 2017 1:22 PM ISTNew Delhi: The Delhi High Court on Friday ordered Baba Ramdev’s Patanjali Ayurved Ltd to stop airing advertisements to promote its brand of...
